AMCoR Asahikawa Medical College
HOME
|

AMCoR:Asahikawa Medical University Collection and Research (旭川医科大学学術成果リポジトリ)は、本学で生産された電子的な知的生産物(学術雑誌論文の原稿・教材・学術資料など)を保存し、原則的に無償で発信するためのインターネット上の保管庫です。

※AMCoRに収録された学術論文のほとんどは、商業出版社や学会出版社の学術雑誌に掲載されたものですが、著作権に係わる出版社の方針により、出版社の条件に添った版を収録しています。そのため実際の誌面とはレイアウトの相違や、字句校正による文言の違いがあり得ますことをあらかじめご了承ください。


| ホーム ニュース ログイン |

Language

AMCoR検索
  
     詳細検索

インデックスツリー

詳細



閲覧数:758
ID 27253992
アイテムタイプ Article
このアイテムを表示する
本文 27253992.pdf
Type : application/pdf Download
Size : 2.4 MB
Last updated : Sep 20, 2017
Downloads : 992

Total downloads since Sep 20, 2017 : 992
タイトル Role of the BrafV637E mutation in hepatocarcinogenesis induced by treatment with diethylnitrosamine in neonatal B6C3F1 mice.
著者
山本, 雅大 (Yamamoto, Masahiro)
田中, 宏樹 (Tanaka, Hiroki)
Bing, Xin
西川, 祐司 (Nishikawa, Yuji)
山崎, 弘資 (Yamazaki, Kosuke)
清水, 惠子 (Shimizu, Keiko)
小川, 勝洋 (Ogawa, Katsuhiro)
上位タイトル
Molecular carcinogenesis Vol.56, No.2  (2017. 2) ,p.478- 488
識別番号
ISSN
0899-1987
DOI 10.1002/mc.22510.
URI http://onlinelibrary.wiley.com/doi/10.1002/mc.22510/full/
その他
PMID:27253992
抄録 The BrafV637E mutation is frequently reported in mouse hepatic tumors, depending on the mouse strain, and corresponds to the human BrafV600E mutation. In this study, we detected the BrafV637E mutation by whole-exome analysis in 4/4 hepatic tumors induced by neonatal treatment with diethylnitrosamine (DEN) in male B6C3F1 mice. We also detected the BrafV637E mutation in 54/63 (85.7%) hepatic lesions, including microscopic foci and grossly visible tumors, by PCR-direct sequencing. Although the mutation was detected in 5/7 (71.4%) hepatic tumors induced by neonatal DEN treatment followed by repeated CCl4 administration, it was not detected in 24 tumors induced by CCl4 treatment without DEN or in eight spontaneous lesions in B6C3F1 mice, suggesting that the mutation is induced by the genotoxic action of DEN. The DEN-induced tumors exhibited hyperphosphorylation of ERK1 and Akt, suggesting that the BrafV637E mutation might activate the MAPK and Akt pathways. Moreover, the DEN-induced tumors overexpressed mRNAs for the oncogene-induced senescence (OIS) markers such as p15Ink4b and p19Arf as well as pro-survival/pro-proliferative cytokines/chemokines such as complement C5/C5a, ICAM-1, IL-1 receptor antagonist and CXCL9, suggesting that the BrafV637E mutation influences the expression of genes involved in either OIS or cellular growth/survival. Liver-specific expression of mutated Braf under control of the albumin enhancer/promoter resulted in an enlarged liver that consisted entirely of small basophilic hepatocytes resembling DEN-induced preneoplastic hepatocytes with ERK1/Akt hyperphosphorylation and C5/C5a overexpression. These results indicate that the BrafV637E mutation induces hepatocytic changes in DEN-induced hepatic tumors. © 2016 The Authors. Molecular Carcinogenesis published by Wiley Periodicals, Inc.
キーワード
BrafV600E transgenic mice
cytokines/chemokines
hepatic tumors
intracellular signaling
whole-exome analysis
資源タイプ text
ジャンル Journal Article
著者版フラグ publisher
Index
/ Public
/ Public / 国外雑誌論文
関連アイテム